Materialise reports Q3 EPS EUR0.03 vs. EUR0.05 last year

Reports Q3 revenue EUR66.26M vs. EUR68.65M last year. CEO Brigitte de Vet-Veithen commented, “I am proud to report that we once more delivered a positive net result and strong cash flow in Q3 of this year. Our Materialise (MTLS) Medical segment posted a quarterly revenue record, growing by more than 10% compared to the same period in 2024, while macro-economic headwinds continued to impact our consolidated revenue, and, in particular, our Materialise Manufacturing segment. We further implemented targeted cost control measures designed to protect our operational profitability without compromising on our continued R&D investments to drive future growth.”